NCT00433966 - Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction | Biotech Hunter

Enrollment

3,602

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

November 30, 2010

Conditions

Myocardial Infarction

Interventions

DRUG

Bivalirudin

Bivalirudin bolus of 0.75 mg/kg IV, followed by an infusion of 1.75 mg/kg/h as soon as logistically feasible (ideally in the emergency room).

DRUG

Unfractionated heparin

60 U/kg of IV heparin, started as soon as possible (ideally in the emergency room).

DEVICE

Bare metal stent

Uncoated bare metal stent

DEVICE

Paclitaxel-eluting stent

slow rate-release paclitaxel-eluting stent

Trial Locations (1)

LeBauer CV Research Foundation, Greensboro